← Kalshi

Medtronic cardiovascular organic growth in fiscal 2027

Open

cardiovascular organic revenue growth in 2027

Selected outcome

Above 6%

94%

Above 6% · 94%

Stored quote · checking the venue

Scheduled end
Aug 31, 2027 ET
Resolution source
Fiscal.ai (opens in a new tab)

Price

Loading price history.

Markets

  • Above 10%

    Will Medtronic plc report Above 10% cardiovascular organic revenue growth in fiscal 2027?

    42%

    Open · ~$0 24h · ~$196 vol

    Bid 37¢ · Ask 46¢

    Open full market view →
  • Above 11%

    Will Medtronic plc report Above 11% cardiovascular organic revenue growth in fiscal 2027?

    20%

    Open · ~$0 24h · ~$0 vol

    Bid 15¢ · Ask 25¢

    Open full market view →
  • Above 6%

    Will Medtronic plc report Above 6% cardiovascular organic revenue growth in fiscal 2027?

    94%

    Open · ~$0 24h · ~$0 vol

    Bid 89¢ · Ask 99¢

    Open full market view →
  • Above 7%

    Will Medtronic plc report Above 7% cardiovascular organic revenue growth in fiscal 2027?

    90%

    Open · ~$0 24h · ~$0 vol

    Bid 85¢ · Ask 95¢

    Open full market view →
  • Above 8%

    Will Medtronic plc report Above 8% cardiovascular organic revenue growth in fiscal 2027?

    80%

    Open · ~$0 24h · ~$0 vol

    Bid 75¢ · Ask 85¢

    Open full market view →
  • Above 9%

    Will Medtronic plc report Above 9% cardiovascular organic revenue growth in fiscal 2027?

    60%

    Open · ~$0 24h · ~$0 vol

    Bid 55¢ · Ask 65¢

    Open full market view →
Event statistics
24h vol
~$0
Volume
~$196
Liquidity
—
Open int.
405 contracts

How this resolves

Scheduled end
Aug 31, 2027 ET
  1. Trading
  2. Closed
  3. In review
  4. Resolved
Rules text

If Medtronic plc reports Above 6% cardiovascular organic revenue growth in fiscal 2027, then the market resolves to Yes.

View on Kalshi